Monte Rosa Therapeutics Inc

NASDAQ:GLUE   10:38:12 AM EDT
7.50
+0.04 (+0.54%)
Earnings Announcements

Monte Rosa Therapeutics Reports First Quarter 2022 Financial Results And Business Updates

Published: 05/11/2022 11:40 GMT
Monte Rosa Therapeutics Inc (GLUE) - Monte Rosa Therapeutics Reports First Quarter 2022 Financial Results and Business Updates.
Monte Rosa Therapeutics - Expects Cash and Cash Equivalents Will Be Sufficient to Fund Planned Operations and Capital Expenditures Into Late 2024.
Qtrly Net Loss per Share Attributable to Common Stockholders Basic and Diluted $0.51.
Q1 Earnings per Share View $-0.52 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.54

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.